Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
Identifieur interne : 002A65 ( Istex/Corpus ); précédent : 002A64; suivant : 002A66Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
Auteurs : Katsuya Morishita ; Shinobu Wakamoto ; Toru Miyazaki ; Shinichiro Sato ; Mitsuhiro Fujihara ; Sadao Kaneko ; Hiroshi Yasuda ; Sadamitsu Yamamoto ; Hiroshi Azuma ; Toshiaki Kato ; Hisami IkedaSource :
- Transfusion [ 0041-1132 ] ; 2005-05.
English descriptors
- Teeft :
- Adverse effects, Adverse reaction, Adverse reactions, Aggregation, Blood center, Blood components, Blood products, Blood recipients, Blood transfusion, Brain surgery, Case report, Cutaneous manifestation, Cytometric, Flow cytometric analysis, Glycoprotein, Healthy adults, Hiroshi azuma, Ikeda, Isoantibody, Moab, Monocyte, Naka, Negative control, Passive transfusion, Plasma protein, Platelet, Platelet membrane glycoprotein, Plts, Posttransfusion, Posttransfusion syndrome, Rantes, Systolic blood pressure, Thrombocytopenia, Transfusion, Transfusion volume.
Abstract
BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.
Url:
DOI: 10.1111/j.1537-2995.2005.04320.x
Links to Exploration step
ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title><author><name sortKey="Morishita, Katsuya" sort="Morishita, Katsuya" uniqKey="Morishita K" first="Katsuya" last="Morishita">Katsuya Morishita</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Wakamoto, Shinobu" sort="Wakamoto, Shinobu" uniqKey="Wakamoto S" first="Shinobu" last="Wakamoto">Shinobu Wakamoto</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Miyazaki, Toru" sort="Miyazaki, Toru" uniqKey="Miyazaki T" first="Toru" last="Miyazaki">Toru Miyazaki</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Sato, Shinichiro" sort="Sato, Shinichiro" uniqKey="Sato S" first="Shinichiro" last="Sato">Shinichiro Sato</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Fujihara, Mitsuhiro" sort="Fujihara, Mitsuhiro" uniqKey="Fujihara M" first="Mitsuhiro" last="Fujihara">Mitsuhiro Fujihara</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Kaneko, Sadao" sort="Kaneko, Sadao" uniqKey="Kaneko S" first="Sadao" last="Kaneko">Sadao Kaneko</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Yasuda, Hiroshi" sort="Yasuda, Hiroshi" uniqKey="Yasuda H" first="Hiroshi" last="Yasuda">Hiroshi Yasuda</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Yamamoto, Sadamitsu" sort="Yamamoto, Sadamitsu" uniqKey="Yamamoto S" first="Sadamitsu" last="Yamamoto">Sadamitsu Yamamoto</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Azuma, Hiroshi" sort="Azuma, Hiroshi" uniqKey="Azuma H" first="Hiroshi" last="Azuma">Hiroshi Azuma</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: azuma@hokkaido.bc.jrc.or.jp</mods:affiliation></affiliation></author><author><name sortKey="Kato, Toshiaki" sort="Kato, Toshiaki" uniqKey="Kato T" first="Toshiaki" last="Kato">Toshiaki Kato</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Ikeda, Hisami" sort="Ikeda, Hisami" uniqKey="Ikeda H" first="Hisami" last="Ikeda">Hisami Ikeda</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1537-2995.2005.04320.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002A65</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title><author><name sortKey="Morishita, Katsuya" sort="Morishita, Katsuya" uniqKey="Morishita K" first="Katsuya" last="Morishita">Katsuya Morishita</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Wakamoto, Shinobu" sort="Wakamoto, Shinobu" uniqKey="Wakamoto S" first="Shinobu" last="Wakamoto">Shinobu Wakamoto</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Miyazaki, Toru" sort="Miyazaki, Toru" uniqKey="Miyazaki T" first="Toru" last="Miyazaki">Toru Miyazaki</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Sato, Shinichiro" sort="Sato, Shinichiro" uniqKey="Sato S" first="Shinichiro" last="Sato">Shinichiro Sato</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Fujihara, Mitsuhiro" sort="Fujihara, Mitsuhiro" uniqKey="Fujihara M" first="Mitsuhiro" last="Fujihara">Mitsuhiro Fujihara</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Kaneko, Sadao" sort="Kaneko, Sadao" uniqKey="Kaneko S" first="Sadao" last="Kaneko">Sadao Kaneko</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Yasuda, Hiroshi" sort="Yasuda, Hiroshi" uniqKey="Yasuda H" first="Hiroshi" last="Yasuda">Hiroshi Yasuda</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Yamamoto, Sadamitsu" sort="Yamamoto, Sadamitsu" uniqKey="Yamamoto S" first="Sadamitsu" last="Yamamoto">Sadamitsu Yamamoto</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Azuma, Hiroshi" sort="Azuma, Hiroshi" uniqKey="Azuma H" first="Hiroshi" last="Azuma">Hiroshi Azuma</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: azuma@hokkaido.bc.jrc.or.jp</mods:affiliation></affiliation></author><author><name sortKey="Kato, Toshiaki" sort="Kato, Toshiaki" uniqKey="Kato T" first="Toshiaki" last="Kato">Toshiaki Kato</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author><author><name sortKey="Ikeda, Hisami" sort="Ikeda, Hisami" uniqKey="Ikeda H" first="Hisami" last="Ikeda">Hisami Ikeda</name><affiliation><mods:affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Transfusion</title><title level="j" type="alt">TRANSFUSION</title><idno type="ISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="803">803</biblScope><biblScope unit="page" to="806">806</biblScope><biblScope unit="page-count">4</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-05">2005-05</date></imprint><idno type="ISSN">0041-1132</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-1132</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adverse effects</term><term>Adverse reaction</term><term>Adverse reactions</term><term>Aggregation</term><term>Blood center</term><term>Blood components</term><term>Blood products</term><term>Blood recipients</term><term>Blood transfusion</term><term>Brain surgery</term><term>Case report</term><term>Cutaneous manifestation</term><term>Cytometric</term><term>Flow cytometric analysis</term><term>Glycoprotein</term><term>Healthy adults</term><term>Hiroshi azuma</term><term>Ikeda</term><term>Isoantibody</term><term>Moab</term><term>Monocyte</term><term>Naka</term><term>Negative control</term><term>Passive transfusion</term><term>Plasma protein</term><term>Platelet</term><term>Platelet membrane glycoprotein</term><term>Plts</term><term>Posttransfusion</term><term>Posttransfusion syndrome</term><term>Rantes</term><term>Systolic blood pressure</term><term>Thrombocytopenia</term><term>Transfusion</term><term>Transfusion volume</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>transfusion</json:string><json:string>plts</json:string><json:string>thrombocytopenia</json:string><json:string>platelet</json:string><json:string>isoantibody</json:string><json:string>passive transfusion</json:string><json:string>glycoprotein</json:string><json:string>naka</json:string><json:string>posttransfusion</json:string><json:string>blood products</json:string><json:string>cytometric</json:string><json:string>aggregation</json:string><json:string>rantes</json:string><json:string>ikeda</json:string><json:string>monocyte</json:string><json:string>adverse reactions</json:string><json:string>moab</json:string><json:string>flow cytometric analysis</json:string><json:string>negative control</json:string><json:string>transfusion volume</json:string><json:string>healthy adults</json:string><json:string>brain surgery</json:string><json:string>blood transfusion</json:string><json:string>cutaneous manifestation</json:string><json:string>blood center</json:string><json:string>hiroshi azuma</json:string><json:string>plasma protein</json:string><json:string>adverse reaction</json:string><json:string>systolic blood pressure</json:string><json:string>posttransfusion syndrome</json:string><json:string>blood recipients</json:string><json:string>case report</json:string><json:string>blood components</json:string><json:string>adverse effects</json:string><json:string>platelet membrane glycoprotein</json:string></teeft></keywords><author><json:item><name>Katsuya Morishita</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Shinobu Wakamoto</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Toru Miyazaki</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Shinichiro Sato</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Mitsuhiro Fujihara</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Sadao Kaneko</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Hiroshi Yasuda</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Sadamitsu Yamamoto</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Hiroshi Azuma</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string><json:string>E-mail: azuma@hokkaido.bc.jrc.or.jp</json:string></affiliations></json:item><json:item><name>Toshiaki Kato</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item><json:item><name>Hisami Ikeda</name><affiliations><json:string>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</json:string></affiliations></json:item></author><articleId><json:string>TRF04320</json:string></articleId><arkIstex>ark:/67375/WNG-N1N17DR8-0</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</abstract><qualityIndicators><score>6.747</score><pdfWordCount>2335</pdfWordCount><pdfCharCount>15331</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>593.583 x 783.039 pts</pdfPageSize><pdfWordsPerPage>584</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>201</abstractWordCount><abstractCharCount>1464</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title><pmid><json:string>15847672</json:string></pmid><genre><json:string>article</json:string></genre><host><title>Transfusion</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1537-2995</json:string></doi><issn><json:string>0041-1132</json:string></issn><eissn><json:string>1537-2995</json:string></eissn><publisherId><json:string>TRF</json:string></publisherId><volume>45</volume><issue>5</issue><pages><first>803</first><last>806</last><total>4</total></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2005</json:string></date><geogName></geogName><orgName><json:string>Keiwakai Ebetsu Hospital, Ebetsu, Japan</json:string><json:string>Kashiwaba Neurosurgical Hospital, Sapporo</json:string><json:string>Immunotech, Marseille, France</json:string><json:string>Hokkaido Red Cross Blood Center</json:string><json:string>Hokkaido Red Cross Blood Center, Sapporo</json:string><json:string>D Systems, Minneapolis</json:string><json:string>Immunotech</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>The</json:string></persName><placeName><json:string>San Jose</json:string><json:string>Japan</json:string><json:string>Tokyo</json:string><json:string>CA</json:string><json:string>Sapporo</json:string></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-N1N17DR8-0</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - hematology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - cardiovascular system & hematology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Hematology</json:string><json:string>1 - Life Sciences</json:string><json:string>2 - Immunology and Microbiology</json:string><json:string>3 - Immunology</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Immunology and Allergy</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2005</publicationDate><copyrightDate>2005</copyrightDate><doi><json:string>10.1111/j.1537-2995.2005.04320.x</json:string></doi><id>1561F0D665871531FCF0027DC6D3353D8954A606</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title><title level="a" type="short">ADVERSE REACTION BY FFP WITH ANTI‐CD36</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-05"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title><title level="a" type="short">ADVERSE REACTION BY FFP WITH ANTI‐CD36</title><author xml:id="author-0000"><persName><forename type="first">Katsuya</forename><surname>Morishita</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Shinobu</forename><surname>Wakamoto</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Toru</forename><surname>Miyazaki</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Shinichiro</forename><surname>Sato</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Mitsuhiro</forename><surname>Fujihara</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Sadao</forename><surname>Kaneko</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">Hiroshi</forename><surname>Yasuda</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">Sadamitsu</forename><surname>Yamamoto</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0008" role="corresp"><persName><forename type="first">Hiroshi</forename><surname>Azuma</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0009"><persName><forename type="first">Toshiaki</forename><surname>Kato</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><author xml:id="author-0010"><persName><forename type="first">Hisami</forename><surname>Ikeda</surname></persName><affiliation><orgName type="institution">From the Hokkaido Red Cross Blood Center</orgName><orgName type="institution">Sapporo; the Kashiwaba Neurosurgical Hospital</orgName><orgName type="institution">Sapporo; and the Keiwakai Ebetsu Hospital</orgName><address><addrLine>Ebetsu</addrLine><addrLine>Japan.</addrLine><country key="JP" xml:lang="en">JAPAN</country></address></affiliation></author><idno type="istex">1561F0D665871531FCF0027DC6D3353D8954A606</idno><idno type="ark">ark:/67375/WNG-N1N17DR8-0</idno><idno type="DOI">10.1111/j.1537-2995.2005.04320.x</idno><idno type="unit">TRF04320</idno><idno type="toTypesetVersion">file:TRF.TRF04320.pdf</idno></analytic><monogr><title level="j" type="main">Transfusion</title><title level="j" type="alt">TRANSFUSION</title><idno type="pISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><idno type="book-DOI">10.1111/(ISSN)1537-2995</idno><idno type="book-part-DOI">10.1111/trf.2005.45.issue-5</idno><idno type="product">TRF</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="803">803</biblScope><biblScope unit="page" to="806">806</biblScope><biblScope unit="page-count">4</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-05"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><p><hi rend="bold">BACKGROUND:</hi> Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients.</p><p><hi rend="bold">CASE REPORT:</hi> A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids.</p><p><hi rend="bold">RESULTS:</hi> Her pretransfusion PLT count was 17.1 × 10<hi rend="superscript">4</hi> per µL. It decreased to 1.9 × 10<hi rend="superscript">4</hi> per µL 12 hours after transfusion and recovered to 15.4 × 10<hi rend="superscript">4</hi> per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults.</p><p><hi rend="bold">CONCLUSION:</hi> This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</p></abstract><textClass><keywords rend="tocHeading1"><term>TRANSFUSION COMPLICATIONS</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Science Inc</publisherName><publisherLoc>Oxford, UK and Malden, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1537-2995</doi><issn type="print">0041-1132</issn><issn type="electronic">1537-2995</issn><idGroup><id type="product" value="TRF"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="TRANSFUSION">Transfusion</title></titleGroup></publicationMeta><publicationMeta level="part" position="05005"><doi origin="wiley">10.1111/trf.2005.45.issue-5</doi><numberingGroup><numbering type="journalVolume" number="45">45</numbering><numbering type="journalIssue" number="5">5</numbering></numberingGroup><coverDate startDate="2005-05">May 2005</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="24" status="forIssue"><doi origin="wiley">10.1111/j.1537-2995.2005.04320.x</doi><idGroup><id type="unit" value="TRF04320"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="tocHeading1">TRANSFUSION COMPLICATIONS</title></titleGroup><eventGroup><event type="firstOnline" date="2005-04-11"></event><event type="publishedOnlineFinalForm" date="2005-04-11"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-03"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="803">803</numbering><numbering type="pageLast" number="806">806</numbering></numberingGroup><correspondenceTo>Hiroshi Azuma, Hokkaido Red Cross Blood Center, Yamanote 2‐2, Nishi‐ku, Sapporo, Japan 063‐0002; e‐mail: <email>azuma@hokkaido.bc.jrc.or.jp</email>.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:TRF.TRF04320.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received for publication August 4, 2004; revision received October 12, 2004, and accepted October 26, 2004.</unparsedEditorialHistory><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="1"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="20"></count><count type="wordTotal" number="2039"></count><count type="linksPubMed" number="0"></count><count type="linksCrossRef" number="0"></count></countGroup><titleGroup><title type="main">Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Nak<sup>a</sup>) isoantibody</title><title type="shortAuthors">MORISHITA ET AL.</title><title type="short">ADVERSE REACTION BY FFP WITH ANTI‐CD36</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>Katsuya</givenNames><familyName>Morishita</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>Shinobu</givenNames><familyName>Wakamoto</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>Toru</givenNames><familyName>Miyazaki</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a1"><personName><givenNames>Shinichiro</givenNames><familyName>Sato</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a1"><personName><givenNames>Mitsuhiro</givenNames><familyName>Fujihara</familyName></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#a1"><personName><givenNames>Sadao</givenNames><familyName>Kaneko</familyName></personName></creator><creator creatorRole="author" xml:id="cr7" affiliationRef="#a1"><personName><givenNames>Hiroshi</givenNames><familyName>Yasuda</familyName></personName></creator><creator creatorRole="author" xml:id="cr8" affiliationRef="#a1"><personName><givenNames>Sadamitsu</givenNames><familyName>Yamamoto</familyName></personName></creator><creator creatorRole="author" xml:id="cr9" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Hiroshi</givenNames><familyName>Azuma</familyName></personName></creator><creator creatorRole="author" xml:id="cr10" affiliationRef="#a1"><personName><givenNames>Toshiaki</givenNames><familyName>Kato</familyName></personName></creator><creator creatorRole="author" xml:id="cr11" affiliationRef="#a1"><personName><givenNames>Hisami</givenNames><familyName>Ikeda</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="JP"><unparsedAffiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><p><b>BACKGROUND:</b> Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients.</p><p><b>CASE REPORT:</b> A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids.</p><p><b>RESULTS:</b> Her pretransfusion PLT count was 17.1 × 10<sup>4</sup> per µL. It decreased to 1.9 × 10<sup>4</sup> per µL 12 hours after transfusion and recovered to 15.4 × 10<sup>4</sup> per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults.</p><p><b>CONCLUSION:</b> This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>ADVERSE REACTION BY FFP WITH ANTI‐CD36</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody</title></titleInfo><name type="personal"><namePart type="given">Katsuya</namePart><namePart type="family">Morishita</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Shinobu</namePart><namePart type="family">Wakamoto</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Toru</namePart><namePart type="family">Miyazaki</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Shinichiro</namePart><namePart type="family">Sato</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Mitsuhiro</namePart><namePart type="family">Fujihara</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sadao</namePart><namePart type="family">Kaneko</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hiroshi</namePart><namePart type="family">Yasuda</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sadamitsu</namePart><namePart type="family">Yamamoto</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hiroshi</namePart><namePart type="family">Azuma</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><affiliation>E-mail: azuma@hokkaido.bc.jrc.or.jp</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Toshiaki</namePart><namePart type="family">Kato</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hisami</namePart><namePart type="family">Ikeda</namePart><affiliation>From the Hokkaido Red Cross Blood Center, Sapporo; the Kashiwaba Neurosurgical Hospital, Sapporo; and the Keiwakai Ebetsu Hospital, Ebetsu, Japan.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Science Inc</publisher><place><placeTerm type="text">Oxford, UK and Malden, USA</placeTerm></place><dateIssued encoding="w3cdtf">2005-05</dateIssued><edition>Received for publication August 4, 2004; revision received October 12, 2004, and accepted October 26, 2004.</edition><copyrightDate encoding="w3cdtf">2005</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">2</extent><extent unit="tables">1</extent><extent unit="formulas">0</extent><extent unit="references">20</extent><extent unit="linksCrossRef">0</extent><extent unit="words">2039</extent></physicalDescription><abstract lang="en">BACKGROUND: Anti‐CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura–like syndrome. There are few reports, however, about the effects of passively transfused blood products containing this isoantibody on recipients. CASE REPORT: A 67‐year‐old Japanese woman underwent brain surgery. On the 6th postoperative day, the patient experienced tightness of the chest and nausea after receiving a transfusion of fresh frozen plasma (FFP). When she manifested hypotension, the transfusion was discontinued. No cutaneous manifestation was observed. The patient's condition gradually improved soon after the administration of steroids. RESULTS: Her pretransfusion PLT count was 17.1 × 104 per µL. It decreased to 1.9 × 104 per µL 12 hours after transfusion and recovered to 15.4 × 104 per µL 8 days after transfusion. The donor of the FFP had a Type I CD36 deficiency. Flow cytometric analysis identified anti‐CD36 isoantibody in the FFP. The cross‐match between the patient's PLTs and the FFP was positive. The FFP induced the aggregation of PLTs derived from healthy adults. CONCLUSION: This is the first reported case of life‐threatening adverse effects and thrombocytopenia caused by passively transfused anti‐CD36 isoantibody. The possibility of passive infusion of this antibody should be considered in the evaluation of life‐threatening transfusion reactions followed by thrombocytopenia.</abstract><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0041-1132</identifier><identifier type="eISSN">1537-2995</identifier><identifier type="DOI">10.1111/(ISSN)1537-2995</identifier><identifier type="PublisherID">TRF</identifier><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>803</start><end>806</end><total>4</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Identification of the platelet‐specific alloantigen, Naka, on platelet membrane glycoprotein IV</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Tomiyama</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Take</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Ikeda</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tomiyama Y, Take H, Ikeda H, et al. Identification of the platelet‐specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood 1990;75: 684‐7.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>684</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>684</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine</title></titleInfo><name type="personal"><namePart type="given">DE</namePart><namePart type="family">Greenwalt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RH</namePart><namePart type="family">Lipsky</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CF</namePart><namePart type="family">Ockenhouse</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Greenwalt DE, Lipsky RH, Ockenhouse CF, et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992;80: 1105‐15.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>1105</start><end>15</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>1105</start><end>15</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Yamamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Akamatsu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Sakuraba</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yamazaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Tanoue</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994;83: 392‐7.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>392</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>392</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka‐platelets lack detectable gpIV (CD36)</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Yamamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Ikeda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NN</namePart><namePart type="family">Tandon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yamamoto N, Ikeda H, Tandon NN, et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka‐platelets lack detectable gpIV (CD36). Blood 1990;76: 1698‐703.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>1698</start><end>703</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>1698</start><end>703</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Phenotype‐genotype correlation in CD36 deficiency types I and II</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yanai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Chiba</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Fujiwara</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yanai H, Chiba H, Fujiwara H, et al. Phenotype‐genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000;84: 436‐41.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>436</start><end>41</end></extent></part><relatedItem type="host"><titleInfo><title>Thromb Haemost</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>436</start><end>41</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>A new platelet‐specific antigen, Naka, involved in the refractoriness of HLA‐matched platelet Transfusion</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Ikeda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Mitani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ohnuma</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ikeda H, Mitani T, Ohnuma M, et al. A new platelet‐specific antigen, Naka, involved in the refractoriness of HLA‐matched platelet Transfusion. Vox Sang 1989;57: 213‐7.</note><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>213</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>213</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Posttransfusion purpura–like syndrome associated with CD36 (Naka) isoimmunization</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Bierling</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Godeau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Fromont</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bierling P, Godeau B, Fromont P, et al. Posttransfusion purpura–like syndrome associated with CD36 (Naka) isoimmunization. Transfusion 1995;35: 777‐82.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>777</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>777</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens</title></titleInfo><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Moses</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DF</namePart><namePart type="family">Stroncek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KM</namePart><namePart type="family">Cipolone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FM</namePart><namePart type="family">Marincola</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moses LA, Stroncek DF, Cipolone KM, Marincola FM. Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens. Transfusion 2000;40: 861‐6.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>861</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>861</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Detection of platelet antibodies by a newly developed mixed agglutination with platelets</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Shibata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Juji</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Nishizawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shibata Y, Juji T, Nishizawa Y, et al. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41: 25‐31.</note><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>25</start><end>31</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>25</start><end>31</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Frozen‐stored granulocytes can be used for an immunofluorescence test to detect granulocyte antibodies</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Nishimura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Mitsunaga</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Juji</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nishimura M, Mitsunaga S, Juji T. Frozen‐stored granulocytes can be used for an immunofluorescence test to detect granulocyte antibodies. Transfusion 2001;41: 1268‐72.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>1268</start><end>72</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>1268</start><end>72</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Flow cytometric analysis in platelet crossmatching using a platelet suspension immunofluorescence test</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Skogen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Christiansen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Husebekk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Skogen B, Christiansen D, Husebekk A. Flow cytometric analysis in platelet crossmatching using a platelet suspension immunofluorescence test. Transfusion 1995;35: 832‐6.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>832</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>832</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Post‐transfusion purpura secondary to passive transfer of anti‐PlA1 by blood transfusion</title></titleInfo><name type="personal"><namePart type="given">PJ</namePart><namePart type="family">Ballem</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NA</namePart><namePart type="family">Buskard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Decary</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Doubroff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ballem PJ, Buskard NA, Decary F, Doubroff P. Post‐transfusion purpura secondary to passive transfer of anti‐PlA1 by blood transfusion. Br J Haematol 1987;66: 113‐4.</note><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>113</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Haematol</title></titleInfo><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>113</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Severe acute thrombocytopenia following infusion of plasma containing anti PlA1</title></titleInfo><name type="personal"><namePart type="given">TS</namePart><namePart type="family">Nijjar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IA</namePart><namePart type="family">Bonacosa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LG</namePart><namePart type="family">Israels</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nijjar TS, Bonacosa IA, Israels LG. Severe acute thrombocytopenia following infusion of plasma containing anti PlA1. Am J Hematol 1987;25: 219‐21.</note><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>219</start><end>21</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Hematol</title></titleInfo><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>219</start><end>21</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>Posttransfusion thrombocytopenia associated with passive transfusion of a platelet‐specific antibody</title></titleInfo><name type="personal"><namePart type="given">EP</namePart><namePart type="family">Scott</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Moilan‐Bergeland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Dalmasso</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Scott EP, Moilan‐Bergeland J, Dalmasso AP. Posttransfusion thrombocytopenia associated with passive transfusion of a platelet‐specific antibody. Transfusion 1988;28: 73‐6.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>73</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>73</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Thrombocytopenia caused by passive transfusion of anti‐glycoprotein Ia/IIa alloantibody (anti‐HPA‐5b)</title></titleInfo><name type="personal"><namePart type="given">TE</namePart><namePart type="family">Warkentin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JW</namePart><namePart type="family">Smith</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CPM</namePart><namePart type="family">Hayward</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Ali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JG</namePart><namePart type="family">Kelton</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Warkentin TE, Smith JW, Hayward CPM, Ali AM, Kelton JG. Thrombocytopenia caused by passive transfusion of anti‐glycoprotein Ia/IIa alloantibody (anti‐HPA‐5b). Blood 1992;79: 2480‐4.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>2480</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>2480</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Neonatal alloimmune thrombocytopenia due to anti‐Naka</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kankirawatana</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Kupatawintu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Juji</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kankirawatana S, Kupatawintu P, Juji T, et al. Neonatal alloimmune thrombocytopenia due to anti‐Naka. Transfusion 2001;41: 375‐7.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>375</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>375</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature</title></titleInfo><name type="personal"><namePart type="given">BR</namePart><namePart type="family">Curtis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Ali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Glazier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Curtis BR, Ali S, Glazier AM, et al. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion 2002;42: 1173‐9.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1173</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1173</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIa transgenic mice: the interplay among antibody, spleen, and Fc receptor</title></titleInfo><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Taylor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Reilly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AD</namePart><namePart type="family">Schreiber</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Taylor SM, Reilly MP, Schreiber AD, et al. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIa transgenic mice: the interplay among antibody, spleen, and Fc receptor. Blood 2000;96: 4254‐60.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>4254</start><end>60</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>4254</start><end>60</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Human platelet antigen‐1a antibodies induce the release of the chemokine RANTES from human platelets</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dettke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dreer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Hocker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Panzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dettke M, Dreer M, Hocker P, Panzer S. Human platelet antigen‐1a antibodies induce the release of the chemokine RANTES from human platelets. Vox Sang 2001;81: 199‐203.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>199</start><end>203</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>199</start><end>203</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>Heterogeneity of platelet responsiveness to anti‐CD36 antibodies in plasma associated with adverse transfusion reactions</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Wakamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fujihara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Urushibara</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wakamoto S, Fujihara M, Urushibara N. Heterogeneity of platelet responsiveness to anti‐CD36 antibodies in plasma associated with adverse transfusion reactions. Vox Sang 2005;88: 41‐51.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>41</start><end>51</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>41</start><end>51</end></extent></part></relatedItem></relatedItem><identifier type="istex">1561F0D665871531FCF0027DC6D3353D8954A606</identifier><identifier type="ark">ark:/67375/WNG-N1N17DR8-0</identifier><identifier type="DOI">10.1111/j.1537-2995.2005.04320.x</identifier><identifier type="ArticleID">TRF04320</identifier><accessCondition type="use and reproduction" contentType="copyright">© Wiley. All rights reserved.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-N1N17DR8-0/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A65 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002A65 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:1561F0D665871531FCF0027DC6D3353D8954A606
|texte= Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
}}
| This area was generated with Dilib version V0.6.33. |  |